CTP Acting Director Statement: New Steps Forward in Accelerating Innovation and Efficiency in Product Review
The Acting Director of the Center for Tobacco Products (CTP), Bret Koplow, Ph.D. J.D., has issued a statement on how the Agency is taking new steps forward in accelerating innovation and efficiency in product review.
Premarket application review is foundational to establishing a well-regulated marketplace. CTP is identifying and deploying lessons learned in the course of having taken action over the past five years on premarket tobacco product applications (PMTAs) for nearly 27 million tobacco products. CTP's staff are working diligently to efficiently evaluate applications, as evidenced by the fact that, in 2025, CTP reduced the backlog of applications by approximately 70 percent. By more efficiently evaluating product applications, CTP can better ensure that products meeting the public health standard in the law are available to the adult tobacco users who might use them to reduce their risks of premature death and chronic disease.
Read the full statement to learn about some of the areas in which CTP is making progress.
|
